If you liked this article you might like

Biogen Should Either a Buyer or a Seller Be
Here Are Some Small-Cap Pharma M&A Targets After Relypsa Deal
Investors Scour Big Pharma M&A Scene for Next Big Takeover
Strong On High Relative Volume: ACADIA Pharmaceuticals (ACAD)